Highmark Inc. Publishes Commercial Coverage Policy for Nerivio ®, a Drug-Free, Dual Use Treatment for Adolescents and Adults Living with Migraine Highmark's coverage decision for the Nerivio REN ...
Migraine Again on MSN
Nurtec ODT: FDA approved as the only migraine medication for prevention and acute treatment
Discover how rimegepant (Nurtec ODT) works for both migraine treatment and prevention. Learn about the approved age range, dosage, and how long it takes to see results.
Tonix Pharmaceuticals is trying to start a conversation about a potential shortcoming of oral migraine drugs, kicking off a national campaign to raise awareness of a condition that can affect ...
Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions, today announced that health insurance coverage for its ...
Strategic Acquisition Helps Build Tonix’s Commercial Capabilities and Infrastructure Ahead of Potential Launch of TNX-102 SL for the Treatment of Fibromyalgia Acute Migraine Products Complement ...
Strategic Acquisition Helps Build Tonix’s Commercial Capabilities and Infrastructure Ahead of Potential Launch of TNX-102 SL for the Management of Fibromyalgia Acquisition of Zembrace® SymTouch® ...
Many people with migraine manage their condition with a combination of medications and nondrug treatments. Nerivio is an evidence-based option that, according to a study funded by manufacturer ...
Vlad Coric has led one of Connecticut’s most successful homegrown bioscience companies. Under Coric’s leadership, Biohaven Pharmaceuticals’ blockbuster migraine drug Nurtec ODT became a top-prescribed ...
Qulipta (atogepant), a medication approved in the U.S. for the prevention of episodic migraine, has now been approved for chronic migraine prevention, too. Qulipta’s maker, AbbVie, announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results